Next-Gen Urethral Stricture Treatment Devices: Market Forecast, Transformation, and Long-Term Trajectories
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Is the Current and Projected Market Size of the Urethral Stricture Treatment Devices Market Through 2034?
The market for devices used in the treatment of urethral strictures has seen robust growth in recent times. The market value is set to increase from $1.37 billion in 2024 to $1.48 billion in 2025, marking a compound annual growth rate (CAGR) of 8.3%. Several factors like the heightened occurrence of urethral strictures, the growing preference for minimally invasive procedures, heightened consciousness about urological conditions, increased healthcare spending in developed regions, and enhanced diagnostics have contributed to the growth observed in the historic period.
The market for urethral stricture treatment devices is set to experience significant growth in the upcoming years, projected to escalate to $2.01 billion by 2029 with a compound annual growth rate (CAGR) of 8.0%. The expansion during the forecast period is influenced by factors such as an increasing preference for outpatient procedures, emphasized attention to patient-centric care, the development of healthcare infrastructure in blossoming markets, a surge in trauma-related strictures cases, and healthcare organizations’ awareness initiatives. Some dominant trends for the forecast timeframe include a transition towards less invasive procedures, the application of AI in diagnostic equipment, progressive enhancements in surgical devices, breakthroughs in medical imaging methods, and an emphasis on individualized treatment strategies.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20986&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Urethral Stricture Treatment Devices Market?
The urethral stricture treatment devices market is expected to be boosted by the increasing incidence of benign prostatic hyperplasia (BPH) and neurogenic bladder. BPH is a common condition among older men, where the prostate gland gets enlarged, often leading to urinary obstruction and elevating the risk of urethral strictures. The growth in BPH is primarily attributed to aging, particularly in men over 50, and its development is influenced by factors such as lifestyle, hormonal changes, and chronic conditions. Urethral stricture treatment devices are frequently used for urological conditions like BPH, where post-surgical complications or prolonged catheterization can cause the urethra to narrow. Interventions using dilators, stents, or urethrotomy tools are necessary to restore normal urinary flow in such cases. As per a report by the Royal Pharmaceutical Society, a professional body based in the UK, in September 2023, about 3 million people in the UK suffer from BPH. The condition affects around 50% of men aged 60-70 years and increases to 90% in men aged over 80 years. Consequently, the growing prevalence of BPH and neurogenic bladder is expected to stimulate the urethral stricture treatment devices market.
Which Key Market Segments Comprise the Urethral Stricture Treatment Devices Market and Drive Its Revenue Growth?
The urethral stricture treatment devices market covered in this report is segmented –
1) By Product Type: Urethral Dilators, Urethral Stents, Urethral Balloon Dilation Catheters, Urinary Catheters
2) By Stricture Location: Anterior, Posterior
3) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Urethral Dilators: Semi-Rigid Urethral Dilators, Flexible Urethral Dilators, Balloon Urethral Dilators, Graded Urethral Dilators
2) By Urethral Stents: Self-Expanding Urethral Stents, Balloon-Expandable Urethral Stents, Metallic Urethral Stents, Silicone Urethral Stents
3) By Urethral Balloon Dilation Catheters: Single-Balloon Dilation Catheters, Double-Balloon Dilation Catheters, Coaxial Balloon Dilation Catheters, Hydrophilic-Coated Balloon Dilation Catheters
4) By Urinary Catheters: Foley Urinary Catheters, Intermittent Urinary Catheters, External Urinary Catheters, Supra-Pubic Urinary Catheters
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=20986&type=smp
Which Areas Are Leading Regions in the Urethral Stricture Treatment Devices Market Expansion Across the Globe?
North America was the largest region in the urethral stricture treatment devices market in 2024. The regions covered in the urethral stricture treatment devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in the Urethral Stricture Treatment Devices Market Over the Coming Years?
Prominent businesses in the urethral stricture treatment devices market are opting for strategic partnerships to boost technological collaborations and broaden their market presence. This kind of partnership entangles a cooperative alliance between two or more entities, pooling their resources, know-how, and endeavors to accomplish shared targets or objectives. For example, in April 2024, Laborie Medical Technologies Corp., a company specializing in diagnostic and therapeutic medical technology based in the U.S., formed a partnership with the NHS Specialized Services Device Programme (SSDP), incorporating their Optilume Urethral Drug-Coated Balloon (DCB) into the program. This combined effort provides reimbursement for NHS hospitals in England, enabling broader patient reach for this innovative apparatus. Optilume merges balloon dilation with the delivery of an anti-proliferative drug to curb the relapse of urethral strictures. This low-invasive technology offers a revolutionary alternative to standard surgery or multiple treatments, answering a key requirement in the urology sphere.
View the full report here:
How Is the Urethral Stricture Treatment Devices Market Conceptually Defined?
Urethral stricture treatment devices are medical instruments designed to treat urethral stricture, a condition where the urethra becomes narrowed, often leading to urinary retention and difficulty in urination. These devices help in widening or bypassing the narrowed area of the urethra to restore normal urine flow, with applications in both surgical and non-surgical treatment options.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20986
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
